Funded Startups in Rosario
Seven funded entries are shown for Rosario across biotech, agriculture, financial services, and commerce, but disclosed round sizes are highly uneven.
Seven funded entries are shown for Rosario across biotech, agriculture, financial services, and commerce, but disclosed round sizes are highly uneven. The largest disclosed amount is Agrofy’s $30M Series C on 2021-12-16, which dwarfs the next-largest disclosed rounds at $2M (Bioheuris, 2021-05-06) and $250K (Mycorium Biotech, 2023-05-10). Three of the seven entries (Nativas on 2023-06-20; Michroma on 2023-01-10; both are undisclosed amounts) and two additional rows lack explicit round amounts, creating a disclosure gap of 3/7 explicitly undisclosed amounts.
Date coverage spans 2021-05-06 to 2023-06-20, with recent activity clustering earlier than 2023 only in part: two disclosed entries fall in 2023 (Mycorium Biotech on 2023-05-10 at $250K; Nativas is undisclosed on 2023-06-20), while the disclosed high-value window sits in late 2021 (Agrofy $30M on 2021-12-16). Sector concentration is also noticeable, with Biotechnology appearing in four of the seven rows (Natives excluded, but Mycorium Biotech, Michroma, ArgenTAG, and Bioheuris included), while geography is mostly Rosario, Santa Fe with one out-of-state entry in Rosario, Cordoba (ArgenTAG).
Most recent rounds
7 shownRelated listings
Frequently asked
What’s the largest disclosed round in this Rosario list, and how does it compare to the rest of the disclosed amounts?
Agrofy’s $30M (Series C) on 2021-12-16 is the clear outlier; the next-largest disclosed amount is $2M for Bioheuris on 2021-05-06, with smaller disclosed rounds including Mycorium Biotech’s $250K (2023-05-10) and Let'sBit’s $100K (2022-03-16).
How much of the recent activity is concentrated within a tight date window near the top of the table?
Within the 2023 entries, only two of the seven rows have disclosed amounts: Mycorium Biotech closed on 2023-05-10 at $250K, while Nativas on 2023-06-20 is undisclosed. The only other undisclosed amounts among the seven appear at the 2023 edge as well (Michroma on 2023-01-10), but most disclosed value concentrates in late 2021 with Agrofy’s 2021-12-16 $30M.
Are any sectors over-represented compared to the others in these 7 entries?
Biotechnology appears in 4 of the 7 rows (Mycorium Biotech, Michroma, ArgenTAG, Bioheuris). The remaining categories are singletons here: Agriculture and Farming (Nativas), Financial Services (Let'sBit), and Commerce and Shopping (Agrofy).
Which stage patterns show up, and do disclosed rounds cluster in particular stages?
Disclosed amounts appear across multiple stages, but the largest disclosed value is tied to Series C (Agrofy $30M on 2021-12-16). Smaller disclosed entries span Pre-Seed ($250K for Mycorium Biotech on 2023-05-10; $100K for Let'sBit on 2022-03-16) and entries without a filled stage label (Bioheuris at $2M on 2021-05-06; ArgenTAG at $100K on 2021-06-23).
Do disclosure gaps (undisclosed or blank amounts) affect how easily the funding picture can be compared?
3 of 7 rows explicitly list 'undisclosed' amounts (Nativas 2023-06-20; Michroma 2023-01-10; and the only other explicit undisclosed in the visible set), and additional rows have missing or blank amount information (ArgenTAG shows $100K but its stage field is blank; Bioheuris shows $2M with a blank stage field). Because the biggest disclosed round is $30M (Agrofy), the disclosed subset is easy to benchmark, but comparisons across all seven entries are constrained by missing disclosed amounts.
Is there a geography or city-format inconsistency worth flagging for analysis?
Most rows use Rosario, Santa Fe, Argentina, but one entry is formatted as Rosario, Cordoba, Argentina (ArgenTAG on 2021-06-23). That makes ArgenTAG the only out-of-Santa-Fe geography in this 7-row excerpt, even though the city name remains Rosario.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.